Home › Obesity › Virginia › Norfolk
Obesity clinical trials in Norfolk, VA
5 studies for Obesity are looking for participants at sites in and around Norfolk (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
RecruitingPhase 3
- York Clinical Research, LLC, Norfolk
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
RecruitingPhase 3
- Research Site, Norfolk
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
RecruitingPhase 3
- AMR Clinical, Norfolk
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
RecruitingPhase 2
- Eastern Virginia Medical School (EVMS) Medical Group, Norfolk
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RecruitingPhase 3
- Sentara Health Research Center, Norfolk
About Obesity
Read about the causes of obesity and find out what you can do to decrease your risk of its associated health issues.
More about Obesity on MedlinePlus
Obesity trials in other cities
- Houston, TX43 studies
- Chicago, IL41 studies
- New York City, NY40 studies
- San Antonio, TX40 studies
- Washington, DC33 studies
- Orlando, FL31 studies
- Dallas, TX30 studies
- Boston, MA28 studies
- Las Vegas, NV27 studies
- Miami, FL27 studies
- Baltimore, MD25 studies
- Jacksonville, FL25 studies
Other studies in Norfolk
- Breast Cancer16 studies
- Prostate Cancer8 studies
- Bladder Cancer8 studies
- Ovarian Cancer7 studies
- Non-Small Cell Lung Cancer7 studies
- Abdominal Aortic Aneurysm7 studies
- Heart Failure7 studies
- Cancer (all types)7 studies
- Cardiovascular Disease7 studies
- Spinal Muscular Atrophy6 studies
- Peripheral Arterial Disease5 studies
- Triple-Negative Breast Cancer5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.